TrialThe lancet. Gastroenterology & hepatology2026
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial.
Milind Javle et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it